Canadian marijuana producer Canopy Growth filed a preliminary short-form base shelf prospectus enabling the company to raise up to $2 billion (2.5 billion Canadian dollars) in one or more series or issuances of securities over a 25-month period.
It is believed to be the largest shelf prospectus by a cannabis company.
It signals the company wants to replenish its cash reserves.
Canopy, whose coffers held as much as CA$4.1 billion at the end of 2018, was down to CA$825 million in cash as of 2020.
The filing would clear the way for Canopy to issue common shares, subscription receipts, warrants and units for a 25-month period “or any combination thereof in one or more series or issuances up to an aggregate total offering price of US$2,000,000,000,” according to the filing.
Canopy said it had negative cash flow for both the fiscal year ended March 31, 2020, and the nine-month period ended Dec. 31, 2020.
The preliminary short-form base prospectus is available here.
Canopy’s shares trade as CGC on the Nasdaq and WEED on the Toronto Stock Exchange.
Medical Disclaimer:
The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.
